Our results showed that AdBMP9 inhibited the tumor growth of SK-BR-3 xenografts in vivo, down-regulated the HER2 protein expression and inhibited the phosphorylation of HER2, ERK1/2, and AKT in the xenografts. The gene discussed is AKT1; the disease is neoplasm.